| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/17/2010 | WO2010067769A1 Biosensor for electrochemical measurement of 1,5-anhydroglucitol, and measuring method and measuring kit using the same |
| 06/17/2010 | WO2010067755A1 Therapeutic agent for hypertension, method for treating hypertension, method for diagnosing hypertension, and method for screening therapeutic agent for hypertension |
| 06/17/2010 | WO2010067722A1 Method for evaluating degree of malignancy of breast cancer, and kit for the evaluation |
| 06/17/2010 | WO2010067487A1 Nectin-4 for target genes of cancer therapy and diagnosis |
| 06/17/2010 | WO2010067381A1 Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction |
| 06/17/2010 | WO2010067372A1 Genetic markers of schizophrenia |
| 06/17/2010 | WO2010067316A1 Methods for identifying erbb2 alteration in tumors |
| 06/17/2010 | WO2010067307A2 In vitro methods and compositions for the diagnosis and/or treatment of adenocarcinoma |
| 06/17/2010 | WO2010067208A2 Genotyping dihydropyrimidine dehydrogenase deficiency |
| 06/17/2010 | WO2010067207A1 Biomarkers for insulin sensitizer drug response |
| 06/17/2010 | WO2010067055A1 Enhanced taqman probe based amplification |
| 06/17/2010 | WO2010067019A2 Automated system for the lysis of microorganisms in a sample, and for the extraction and purification of the nucleic acids of said microorganisms for analysis |
| 06/17/2010 | WO2010067013A1 Novel isolated reovirus, and detection methods and kits |
| 06/17/2010 | WO2010066928A1 Tumour subclassification method |
| 06/17/2010 | WO2010066921A2 Device and method for the dynamic study of biofilms on catheters for medical use |
| 06/17/2010 | WO2010066908A1 Use of cyclodextrins to improve the specificity, sensitivity and yield of nucleic acid amplification reactions |
| 06/17/2010 | WO2010066891A2 Method for predicting the response to treatment by tyrosine kinase inhibitors targeting the bcr-abl fusion protein in chronic myeloid leukaemia patients |
| 06/17/2010 | WO2010066885A2 Indexing of nucleic acid populations |
| 06/17/2010 | WO2010066884A1 Method for analysis of nucleic acid populations |
| 06/17/2010 | WO2010066851A1 Neuroblastoma prognostic multigene expression signature |
| 06/17/2010 | WO2010066652A1 Methods and compositions for cancer prognosis |
| 06/17/2010 | WO2010066407A1 Nuclease-free real-time detection of nucleic acids |
| 06/17/2010 | WO2010066384A1 Compositions and methods for micro-rna expression profiling of cancer stem cells |
| 06/17/2010 | WO2010066118A1 Muc13 molecular marker for identifying the f4ac adhesin-caused diarrhea resistance of the weanling pig and the use thereof |
| 06/17/2010 | WO2010066116A1 Construction method and system of fragments assembling scaffold, and genome sequencing device |
| 06/17/2010 | WO2010066115A1 Method and system for lowering time complexity in short sequences assembly |
| 06/17/2010 | WO2010066114A1 Error correcting method of test sequence, corresponding system and gene assembly equipment |
| 06/17/2010 | WO2010066113A1 Composition of fusion proteins of split fluorescent proteins, expression vector, expression stable cell line, and screening method thereof |
| 06/17/2010 | WO2010066046A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms |
| 06/17/2010 | WO2010066018A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
| 06/17/2010 | WO2010047797A3 Single quantum-dot-based aptameric sensors |
| 06/17/2010 | WO2010044932A9 Nanofluidic channels with integrated charge sensors and methods based thereon |
| 06/17/2010 | WO2010040108A8 Method for measuring carbon nanotubes taken-up by a plurality of living cells |
| 06/17/2010 | WO2010036794A8 Methods for identifying modulators of the pp2a b56 beta regulatory subunit |
| 06/17/2010 | WO2010028110A9 Sequence variations in pnpla3 associated with hepatic steatosis |
| 06/17/2010 | WO2010025364A3 A NOVEL LUCIFERASE REPORTER SYSTEM FOR NON-INVASIVE MONITORING OF NFkB ACTIVITY IN VITRO AND IN VIVO |
| 06/17/2010 | WO2010025282A3 Check valve-less fluid-transfer collection assembly and method of using the same |
| 06/17/2010 | WO2010024609A3 Nanoparticle sensor for measuring protease activity and method for manufacturing the same |
| 06/17/2010 | WO2010022391A3 Integrated, automated system for the study of cell and tissue function |
| 06/17/2010 | WO2010022268A9 Markers for assessing the susceptibility of cancer to igf-1r treatment |
| 06/17/2010 | WO2009158606A3 Structure, synthesis, and applications for oligo phenylene ethynylenes |
| 06/17/2010 | WO2009140671A3 Droplet actuator devices and methods for manipulating beads |
| 06/17/2010 | WO2009021683A8 Predictive marker for egfr inhibitor treatment |
| 06/17/2010 | WO2008138553A8 System and method for analyte measurement using a nonlinear sample response |
| 06/17/2010 | WO2005116850A3 Polynucleotides and polypeptides of ovarian cancer |
| 06/17/2010 | US20100154083 Methods and Compositions for the Selection of A Transgenic Plant |
| 06/17/2010 | US20100154071 Fxdy5 modulators for treating, diagnosing, and detecting cancer |
| 06/17/2010 | US20100153019 Least-square deconvolution (lsd): a method to resolve dna mixtures |
| 06/17/2010 | US20100152277 Diacylglycerol acyltransferase assay |
| 06/17/2010 | US20100152215 Methods of identifying activators of lyn kinase |
| 06/17/2010 | US20100152212 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches |
| 06/17/2010 | US20100152202 Tissue Factor Promoter Polymorphisms |
| 06/17/2010 | US20100152136 TP53 Gene expression and uses thereof |
| 06/17/2010 | US20100152129 Novel synergistic combination of gemcitabine with P276-00 or P1446A in treatment of cancer |
| 06/17/2010 | US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases |
| 06/17/2010 | US20100152064 siRNA targeting BCL2L1 |
| 06/17/2010 | US20100152061 Oligonucleotide Primer Set For Amplifying Target Sequence(S) Of Norovirus, Oligonucleotide Probe Or Probe Set Specifically Hybridizing With Target Sequence(S) Of Norovirus, Microarray Immobilized With The Probe Or Probe Set, And Method Of Detecting Norovirus Using The Probe Or Probe Set |
| 06/17/2010 | US20100152058 Cancer markers |
| 06/17/2010 | US20100152055 Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient |
| 06/17/2010 | US20100152053 Method for in vitro monitoring of postoperative changes following liver transplantation |
| 06/17/2010 | US20100152052 Specimens for microanalysis processes |
| 06/17/2010 | US20100152051 Novel method for the identification of clones conferring a desired biological property from an expression library |
| 06/17/2010 | US20100151530 Method for producing plasmid dna on a manufacturing scale |
| 06/17/2010 | US20100151524 Compositions and Methods for Increasing Bone Mineralization |
| 06/17/2010 | US20100151510 Substrate for cell culture, producing method thereof and screening method for cell culture conditions utilizing the same |
| 06/17/2010 | US20100151509 Reagent, kit and method for differentating and counting leukocytes |
| 06/17/2010 | US20100151508 Compounds |
| 06/17/2010 | US20100151507 Cavity Induced Allosteric Modification Of Intermolecular Interactions And Methods Of Identifying Compounds That Effect The Same |
| 06/17/2010 | US20100151506 Chloroacetamidine Based Inhibitors and Activity Based Probes for the Protein Arginine Methytransferases |
| 06/17/2010 | US20100151505 Methods for modulating thermostability and acid tolerance of microbes |
| 06/17/2010 | US20100151503 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 06/17/2010 | US20100151494 Fret protease assays for clostridial toxins |
| 06/17/2010 | US20100151492 Methods for the treatment of infections and tumors |
| 06/17/2010 | US20100151481 Cell-signaling assays |
| 06/17/2010 | US20100151480 Exosome-associated microrna as a diagnostic marker |
| 06/17/2010 | US20100151479 Sensing apparatus and method |
| 06/17/2010 | US20100151478 Methods for disease detection |
| 06/17/2010 | US20100151477 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences |
| 06/17/2010 | US20100151476 Phenylthiocarbamide (ptc) taste receptor |
| 06/17/2010 | US20100151475 Chemical reaction cartridge, its fabrication method, and a chemical reaction cartridge drive system |
| 06/17/2010 | US20100151474 Multifunctional Device For Diagnostics and Method For Testing Biological Objects |
| 06/17/2010 | US20100151473 Methods and compositions for hybridizing nucleic acids |
| 06/17/2010 | US20100151472 Detection Composition |
| 06/17/2010 | US20100151471 Methods of monitoring conditions by sequence analysis |
| 06/17/2010 | US20100151470 Methods and compositions for locating snp heterozygosity for allele specific diagnosis and therapy |
| 06/17/2010 | US20100151469 Sample-processing reagent compositions, methods, and devices |
| 06/17/2010 | US20100151468 Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer |
| 06/17/2010 | US20100151467 Methods and compositions for diagnosing and monitoring transplant rejection |
| 06/17/2010 | US20100151466 Diagnosis and treatment of cervical cancer |
| 06/17/2010 | US20100151465 Selective Capture and Release of Analytes |
| 06/17/2010 | US20100151464 Compositions and methods for preparing oligonucleotide solutions |
| 06/17/2010 | US20100151463 Method for Determining the Likelihood of Response to HER2 Inhibitors |
| 06/17/2010 | US20100151462 Human diabetes susceptibility shank2 gene |
| 06/17/2010 | US20100151461 Genetic markers for schizophrenia and bipolar disorder |
| 06/17/2010 | US20100151460 Systems and Methods for Biological and Chemical Detection, Comprising Automatic Selection of Reagent Sets |
| 06/17/2010 | US20100151459 Marker for detecting the proposed efficacy of treatment |
| 06/17/2010 | US20100151458 Oligoribonucleotides and ribonucleases for cleaving rna |
| 06/17/2010 | US20100151457 Detection of Unhealthy Cell and Uses Thereof |
| 06/17/2010 | US20100151456 Method for the assay of liver fatty acid binding protein, ace and ca 19-9 for the in vitro diagnosis of colorectal cancer |
| 06/17/2010 | US20100151455 Use of base-modified deoxynucleoside triphosphates to improve nucleic acid detection |